January 20, 2025
TOPLINE: Patients with localized renal cell carcinoma (RCC) without obesity or with higher-stage, higher-grade tumours experience increased pre-diagnosis weight loss, ranging from 1.56 kg to 4.45 […]
January 20, 2025
The US Food and Drug Administration (FDA) has approved sotorasib (Lumakras, Amgen Inc.) with panitumumab (Vectibix, Amgen Inc.) for the treatment of certain adult patients with […]
January 17, 2025
The US Food and Drug Administration (FDA) has approved datopotamab deruxtecan for the treatment of certain patients with unresectable or metastatic hormone receptor (HR)-positive, human epidermal […]
January 17, 2025
Cancer deaths have declined by more than a third since the 1990s, but the incidence of many cancer types in women and younger adults is increasing. […]
January 17, 2025
TOPLINE: Using multiparametric MRI (mpMRI) before surgery reduced time to correct treatment by 45 days for patients with muscle invasive bladder cancer. The imaging procedure was […]
January 17, 2025
In response to accumulating research linking alcohol consumption and increased risk for certain cancers, US Surgeon General Vivek Murthy called for the placement of warning labels […]
January 17, 2025
TOPLINE: An analysis of over 1.2 million gynecologic cancer cases revealed a trend towards surgical de-escalation, with researchers observing a growing shift to minimally invasive techniques […]
January 17, 2025
Earlier initiation of digital screening mammography at age 40 years leads to substantial healthcare savings by reducing the cost of breast cancer treatment, according to a […]
January 17, 2025
TOPLINE: A new analysis suggests that Medicare spending on anticancer drugs is not based on a drug’s clinical value, highlighting “a misalignment between drug pricing and […]